Oga Toru, Taniguchi Hiroyuki, Kita Hideo, Tsuboi Tomomasa, Tomii Keisuke, Ando Morihide, Kojima Eiji, Tomioka Hiromi, Taguchi Yoshio, Kaji Yusuke, Maekura Ryoji, Hiraga Toru, Sakai Naoki, Kimura Tomoki, Mishima Michiaki, Windisch Wolfram, Chin Kazuo
Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, Japan.
Respir Investig. 2017 Mar;55(2):166-172. doi: 10.1016/j.resinv.2016.12.003. Epub 2017 Feb 6.
The Severe Respiratory Insufficiency (SRI) Questionnaire was originally developed in German to assess health-related quality of life (HRQL) and was validated as a multidimensional instrument with high psychometric properties in chronic hypercapnic respiratory failure (CHRF) patients receiving noninvasive ventilation (NIV). We aimed to investigate the intercultural adaptation of the Japanese SRI Questionnaire and whether it is a reliable and valid HRQL questionnaire to administer to those patients.
The SRI Questionnaire was adapted to Japanese using a translation and back-translation procedure, followed by equivalency assessment. It was validated in 56 stable outpatients receiving NIV for CHRF, primarily due to chronic obstructive pulmonary disease (COPD) and/or pulmonary tuberculosis sequelae.
Examination of the frequency distribution of the Japanese SRI Questionnaire showed that the subscales and summary were approximately normally distributed and well balanced. There were no significant differences in SRI scores between patients with COPD and pulmonary tuberculosis sequelae. Cronbach׳s α values representing internal consistency of seven SRI subscales ranged from 0.56 to 0.80; attendant symptoms and sleep had the lowest values. Cronbach׳s α value was 0.92 for the SRI summary. The SRI summary score was significantly related to all eight subscales of the Medical Outcomes Study 36-item short form, with correlation coefficients of 0.41-0.66.
The Japanese SRI Questionnaire was produced using a standardized procedure and an equivalency study. It has high psychometric properties with internal consistency and concurrent validity. The Japanese SRI Questionnaire can be used to assess HRQL in patients on NIV for CHRF.
严重呼吸功能不全（SRI）问卷最初以德语编制，用于评估健康相关生活质量（HRQL），并在接受无创通气（NIV）的慢性高碳酸血症呼吸衰竭（CHRF）患者中作为具有高心理测量学特性的多维工具得到验证。我们旨在研究日本版SRI问卷的跨文化适应性，以及它是否是用于这些患者的可靠且有效的HRQL问卷。
采用翻译和回译程序将SRI问卷改编为日语，随后进行等效性评估。在56名接受NIV治疗CHRF的稳定门诊患者中对其进行验证，这些患者主要因慢性阻塞性肺疾病（COPD）和/或肺结核后遗症。
对日本版SRI问卷的频率分布检查显示，各子量表和总分近似正态分布且平衡良好。COPD患者和肺结核后遗症患者的SRI得分无显著差异。代表七个SRI子量表内部一致性的Cronbach's α值范围为0.56至0.80；伴随症状和睡眠的α值最低。SRI总分的Cronbach's α值为0.92。SRI总分与医学结局研究36项简表的所有八个子量表均显著相关，相关系数为0.41 - 0.66。
日本版SRI问卷是采用标准化程序和等效性研究编制的。它具有较高的心理测量学特性，包括内部一致性和同时效度。日本版SRI问卷可用于评估接受NIV治疗CHRF患者的HRQL。
